Silexion Therapeutics Ltd. (SLXN) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Silexion Therapeutics Ltd. (SLXN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.1M, listed on NASDAQ, employing roughly 14 people, carrying a beta of -0.26 to the broader market. Silexion Therapeutics LTD is a biopharmaceutical company specializing in the discovery and advancement of RNA interference (RNAi)-based cancer therapies and their associated delivery systems, with a focus on treating aggressive solid tumors. Led by Ilan Hadar, public since 2024-08-16.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for SLXN as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →